Patents Assigned to TELLURIS BIOTECH INDIA PRIVATE LIMITED
  • Patent number: 11484035
    Abstract: The present invention provides a synergistic composition of a nematicide comprising of a nematicidal peptides derived from CED-4 protein sequence comprising of at least two peptides. The nematicidal peptides individually show 100% nematicidal activity at a concentration of 1 mg/ml, whereas, the combination of at least two peptides in a ratio of 1:1 shows 100% nematicidal activity at concentration as low as 0.8 mg/ml bringing a synergistic effect. This synergistic nematicidal composition is highly economical as it requires 20% less peptide concentration for 100% activity, moreover the composition is environmentally safe and non-toxic to humans and animals.
    Type: Grant
    Filed: March 17, 2018
    Date of Patent: November 1, 2022
    Assignee: TELLURIS BIOTECH INDIA PRIVATE LIMITED
    Inventors: Venu Polineni, Alejandro Calderón Urrea, Glenda W. Polack
  • Patent number: 11369111
    Abstract: The present invention provides a synergistic composition of a nematicide comprising of combination of chalcones, chalcone 17 and chalcone 25, or chalcone 17 and chalcone 30 with potent nematicidal and nematostatic properties. The chalcones individually show 100% nematicidal activity at a concentration as high as 10?2-10?3 M, whereas, the combination of chalcone 17 and chalcone 25, or chalcone 17 and chalcone 30, show 100% nematicidal activity at concentration as low as 10?4-10?6 M bringing a synergistic effect, wherein the ratio of the chalcones is 1:1. These combinations of the chalcones also show potent nematostatic activity compared to each chalcone individually. This synergistic nematicidal composition is environmentally safe and non-toxic to humans and animals.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: June 28, 2022
    Assignee: TELLURIS BIOTECH INDIA PRIVATE LIMITED
    Inventors: Alejandro Calderón-Urrea, Saeed Attar
  • Publication number: 20210195896
    Abstract: The present invention provides a synergistic composition of a nematicide comprising of combination of chalcones, chalcone 17 and chalcone 25, or chalcone 17 and chalcone 30 with potent nematicidal and nematostatic properties. The chalcones individually show 100% nematicidal activity at a concentration as high as 10?2-10?3 M, whereas, the combination of chalcone 17 and chalcone 25, or chalcone 17 and chalcone 30, show 100% nematicidal activity at concentration as low as 10?4-10?6 M bringing a synergistic effect, wherein the ratio of the chalcones is 1:1. These combinations of the chalcones also show potent nematostatic activity compared to each chalcone individually. This synergistic nematicidal composition is environmentally safe and non-toxic to humans and animals.
    Type: Application
    Filed: November 21, 2017
    Publication date: July 1, 2021
    Applicant: TELLURIS BIOTECH INDIA PRIVATE LIMITED
    Inventors: Alejandro CALDERÓN-URREA, Saeed ATTAR
  • Patent number: 10925286
    Abstract: The present invention provides a synergistic composition of a nematicide comprising of a nematicidal peptide, and chalcones, wherein the nematicidal peptide is derived from CED-4 protein sequence is either, Peptide 2, or Peptide 3, or Peptide 12; and chalcones are either chalcone 17, chalcone 25, or chalcone 30. The nematicidal peptides alone show 100% nematicidal activity at a concentration of 1 mg/ml, whereas, when combined with chalcones, 100% nematicidal activity is seen at concentration as low as 0.8 mg/ml bringing a synergistic effect. Another embodiment of the invention provides a method for preparing working solutions of chalcones in aqueous solvents such as water by diluting the stock solution of chalcones, prepared in dimethyl sulfoxide, serially in ethanol and water. The final concentration of chalcone is around 10?4-10?5 M in the nematicidal composition. This synergistic nematicidal composition is environmentally safe and non-toxic to humans and animals.
    Type: Grant
    Filed: March 17, 2018
    Date of Patent: February 23, 2021
    Assignee: TELLURIS BIOTECH INDIA PRIVATE LIMITED
    Inventors: Venu Polineni, Alejandro Calderón Urrea, Glenda W. Polack